Thermodilution versus saline dilution method for vascular access blood flow measurement in high-flux and on-line hemodiafiltration.
Access blood flow (Qa) measurements are one of the most important components in vascular access monitoring programs, even though these indirect methods have only been validated with high-flux hemodialysis (HF; pump flow [Qb] 300 mL/min). This study was to assess the utility from thermodilution (BTM) with respect to the saline dilution method (SDM) in HF and on-line hemodiafiltration (OL-HDF) with routinely prescribed parameters in comparison with validation conditions. Three consecutive sessions were assessed in 31 hemodialysis patients (27AVF). The Bland-Altman method and Lin's concordance coefficient (ρc) were used to study accuracy and precision. We used the student t test for the analysis of Qa-value in the different subgroups. In HF-hemodialysis 1 (Qb 300 mL/min), Qa was 1109 ± 541 mL/min SDM(a) and 1213 ± 639 mL/min BTM (P=.993(a); bias 103.7 mL/min and ρc 0.78). In HF-hemodialysis 2 (Qb 420 mL/min) Qa 1071 ± 578 mL/min SDM (P=1.0(a); -38.2 mL/min and 0.96) and 1216 ± 667 mL/min BTM (P=.992(a); 127.3 mL/min and 0.70). In OL-HDF hemodialysis 3 (Qb 420 mL/min) Qa 1071 ± 510 mL/min SDM (P=1.0(a); -48.4 mL/min and 0.96) and 1219 ± 580 mL/min BTM (P=.977(a); 99.2 mL/min and 0.75). Statistically significant differences were only obtained in patients aged ≥ 65 years old (P=.016) and peripheral vascular disease (P=.007). Our results demonstrate how the saline dilution method was more accurate than thermodilution in the HF and OL-HDF modalities with routinely prescribed parameters. Finally, in this study, advanced age (>65 years old) and peripheral vascular disease were associated with a significantly lower Qa-value.